Target myostatin(GDF8) therapy(Vial Health Technology Inc)

N/A

Report date: 2025/10/31 09:42:07

Base Information

Drug NameTarget myostatin(GDF8) therapy(Vial Health Technology Inc)
Drug Alias NameTarget myostatin therapy(Vial Health Technology Inc)Target GDF8 therapy(Vial Health Technology Inc)Anti-Myostatin(GDF8) mAb(Vial Health Technology Inc)Anti-Myostatin mAb(Vial Health Technology Inc)Anti-GDF8 mAb(Vial Health Technology Inc)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVial Health Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesVial Health Technology Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A